首页> 外国专利> Methods for the diagnosis of a genetic predisposition to cancer associated with variant CDK4 allele

Methods for the diagnosis of a genetic predisposition to cancer associated with variant CDK4 allele

机译:诊断与变异CDK4等位基因相关的癌症遗传易感性的方法

摘要

Protein complexes consisting of a cyclin dependent kinase CDK4 and cyclin D control passage through the G1 checkpoint of the cell cycle by phosphorylating the retinoblastoma protein. The ability of these complexes to phosphorylate RB is inhibited by a family of low molecular weight proteins, including p16, p15 and p18. Germline mutations in the p16 gene have been identified in approximately half of families with hereditary A mutation is described in CDK4 in two unrelated melanoma families that do not carry germline p16 mutations. This CDK4-R24C mutation was detected in 11/11 melanoma patients, 2/17 unaffecteds and 0/5 spouses. This mutation has a specific effect of the p16 binding domain of CDK4, but has no effect on its ability to bind cyclin D and form a functional kinase. Therefore, the germline R24C mutation in CDK4 generates a dominant oncogene that is resistant to normal physiological inhibition by p16.
机译:由细胞周期蛋白依赖性激酶CDK4和细胞周期蛋白D组成的蛋白复合物通过使视网膜母细胞瘤蛋白磷酸化来控制通过细胞周期G1检查点的通道。这些复合物磷酸化RB的能力受到一系列低分子量蛋白质(包括p16,p15和p18)的抑制。已在大约一半具有遗传性的家族中鉴定出p16基因的种系突变。CDK4中描述了两个不携带种系p16突变的无关黑色素瘤家族的CDK4突变。在11/11黑色素瘤患者,2/17未受影响的患者和0/5的配偶中检测到了CDK4-R24C突变。此突变对CDK4的p16结合域具有特定作用,但对其结合细胞周期蛋白D和形成功能性激酶的能力没有影响。因此,CDK4中的种系R24C突变产生显性癌基因,该基因对p16的正常生理抑制具有抵抗力。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号